OpenAI expands initiatives to support journalism from classrooms to newsrooms
OpenAI announced expanded journalism initiatives, including tools, training, and partnerships aimed at students, educators, journalists, and news organizations.
Related Tech News
AI CuratedSafety for Whom? Refusing the Right Subset of a Topic, Not the Whole Topic
The Hugging Face blog post describes a research paper titled 'Safety for Whom? Boundary-Aware Self-Distillation for Controlled LLM Safety Refusal.' It argues that current safety alignment treats harm as a topic-level property, but real deployments need to refuse only a subset of a topic (e.g., political manipulation) while answering benign prompts within the same topic. The paper formalizes this narrow-boundary safety setting and proposes a training method to achieve a sharp refusal step.
Mistral raises €3B as sovereign AI becomes big business
Mistral AI announced a €3 billion Series D round, the largest equity fundraising ever by a European tech company, led by Samsung Electronics. The funds will be used to scale compute capacity, build infrastructure, and expand international footprint. Mistral positions itself as a sovereign AI lab, aiming to address European concerns about dependence on US tech. The company has over 20 countries of operation and focuses on helping governments and corporations leverage AI.
AlphaGenome Atlas: A predictive map of every possible DNA letter change in the human genome
Google DeepMind introduced AlphaGenome Atlas, a searchable platform containing predictions for 9 billion single-nucleotide variants in the human genome. It includes the AlphaGenome Variant Impact score and is available through a free portal, API, and Google Antigravity skill. The company says collaborators have already used it to identify variants in rare disease research.
Google’s Atlas of the human genome could pave the way for new treatments
Google DeepMind has announced AlphaGenome Atlas, described as a predictive map of every possible DNA letter change in the human genome. The tool is intended to accelerate biological research and could lead to new disease treatments. The Verge reports the platform was detailed in a DeepMind blog post, though specific capabilities and validation data are not included in this snippet.